Cogent Biosciences, Inc. (COGT) KPIs and segments
Close on Nov 17, 2026Market cap $4.83BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Cogent Biosciences's business
Cogent Biosciences's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Depreciation Expense($M) | -0.74 | 0.63 | 0.63 | 0.64 | -0.66 | 0.64 | 0.63 | 0.62 | 0.61 | 0.60 | |
Research and Development Software, Facilities and Other Strategic Support($M) | -6.54 | 5.73 | 5.89 | 5.01 | -4.91 | 4.43 | -0.39 | 4.15 | 3.84 | 3.22 | |
Early-stage, Preclinical and Discovery Programs($M) | -11.8 | 14.0 | 9.74 | 10.6 | -10.0 | 9.78 | 8.43 | 7.63 | 5.56 | 6.52 | |
Stock-Based Compensation Expense($M) | -17.1 | 16.9 | 15.8 | 10.6 | -9.72 | 10.0 | 9.98 | 10.4 | 10.0 | 9.39 | |
R&D Personnel Related($M) | -17.6 | 18.0 | 19.2 | 15.2 | -14.6 | 14.9 | 13.8 | 11.7 | 10.8 | 10.7 | |
Other Operational Infrastructure and Advisory Support($M) | -23.3 | 20.2 | 15.6 | 9.11 | -8.58 | 7.12 | 11.2 | 6.20 | 4.76 | 4.70 | |
Late-stage Development($M) | -25.6 | 28.1 | 32.6 | 32.2 | -27.1 | 28.1 | 30.1 | 34.7 | 28.8 | 27.3 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-10.
See a number that looks wrong?